Drug class
Bismuth tripotassium dicitrate (colloidal bismuth subcitrate); gastrointestinal mucosal protectant
Mechanism of action
Acts through several local gastrointestinal mechanisms: forms a protective layer over ulcerated mucosa, increases mucus glycoprotein secretion, inhibits peptic activity and has activity against Helicobacter pylori. Its effects are not adequately described by a single molecular target.
General use cases
- Treatment of gastric and duodenal ulcers
- Part of combination regimens for Helicobacter pylori eradication, according to the current local product information and antimicrobial regimen
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
